Affiliation:
1. Institute of Genetic Engineering and Biotechnology for Postgraduate Studies, University of Baghdad, Baghdad, Iraq
Abstract
Background: The emergence of carbapenem-resistant Enterobacteriaceae, especially Klebsiella pneumoniae, which causes infection associated with
multidrug-resistant strains, is a primary clinical and public health concern. Objectives: This study aimed to evaluate the expression level of bla-IMP and bla-VIM
genes in the presence and absence of meropenem antibiotics. Methods: Eighty K.
pneumoniae isolates were obtained from 250 urine samples collected from patients in Baghdad Hospitals, Iraq, from November 2020 to March 2021. The minimum inhibitory concentrations (MICs) were measured for the isolates by microdilution method. Real-time PCR detected the presence of bla-IMP and bla-VIM
resistance genes. The blah-IMP and bla-VIM gene expression levels were measured by real-time PCR in the presence and absence of meropenem antibiotics.
Results: The results of this study showed that the higher expression level of blaIMP and bla-VIM increased in resistant strains in the presence of meropenem,
where the range of fold for gene expression of bla-VIM was 1.3 to 8.3, while for
bla-IMP gene was 1.5 to 8.4. Conclusion: In conclusion, the overuse of meropenem and imipenem antibiotics in the treatment of K. pneumoniae may lead to
an increase in the resistance of this species to carbapenems and cephalosporins,
and There was a correlation between the meropenem resistance in K. pneumoniae
isolates and the gene expression of the tow genes bla-IMP and bla-VIM
Keywords: Carbapenem Resistance, Klebsiella pneumoniae, bla-IMP, bla-VIM,
Gene expression, UTI.
Subject
Infectious Diseases,Applied Microbiology and Biotechnology,Epidemiology,Biotechnology
Reference42 articles.
1. 1 Doesschate; T.; van der Vaart; T. W.; Damen; J. A. A.; Bonten; M. J.; & van Werkhoven; C. H.
2. Carbapenem-alternative strategies for complicated urinary tract infections: a systematic review of
3. randomized controlled trials. Journal of Infection; 2020; 81(4); 499-509.
4. 2 Kritsotakis, E. I., Kontopidou, F., Astrinaki, E., Roumbelaki, M., Ioannidou, E., & Gikas, A. Prevalence,
5. incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献